{
    "clinical_study": {
        "@rank": "70582", 
        "arm_group": {
            "arm_group_label": "buprenorphine/naloxone", 
            "description": "Opioid substitution therapy patient taking buprenorphine/naloxone, MedSignals and smartphone app."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the usability of an interactive smartphone\n      application (app) designed to engage and support patients receiving bup/nal."
        }, 
        "brief_title": "Using mHealth to Aid Opioid Medication Adherence Pilot Study", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Opioid Dependence", 
        "condition_browse": {
            "mesh_term": "Opioid-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate the usability of a medication management aid for\n      opioid dependence named SubAID. The SubAID system is a smartphone application and medication\n      monitor designed to optimize adherence behaviors of an OD patient responsible for\n      administering bup/nal maintenance therapy medication.\n\n      Usability of the SubAID system will be tested utilizing a 3-Stage study design over a 5 week\n      period among a cohort of subjects prescribed bup/nal and undergoing OST.\n\n        -  Stage 1 - 1 week: Participants will use only an electronic medication monitor\n           (MedSignals) in control mode to passively record baseline adherence to medication.\n\n        -  Stage 2 - 2 weeks: Participants will use MedSignals in control mode and the smartphone\n           application.\n\n        -  Stage 3 - 2 weeks: Participants will use MedSignals in active mode and the smartphone\n           application.\n\n      After each stage usability assessments will be conducted to evaluate satisfaction with the\n      products from participants."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 21 years of age\n\n          -  Physician diagnosis of opioid dependence (OD)\n\n          -  Prescribed buprenorphine/naloxone (bup/nal) and acclimated to medication.\n\n          -  Able to speak and read English\n\n          -  Willing to provide written informed consent prior to study entry\n\n          -  Able to understand the study\n\n          -  Ownership of an Android or iPhone smartphone\n\n        Exclusion Criteria:\n\n          -  Having any concurrent medical or psychiatric condition that, in the investigator's\n             opinion, may preclude participation in this study; or\n\n          -  Cognitive or other impairment that would interfere with completing a\n             self-administered questionnaire."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "community sample"
            }
        }, 
        "enrollment": {
            "#text": "9", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02017041", 
            "org_study_id": "HHSN271201300015C-1", 
            "secondary_id": "HHSN271201300015C"
        }, 
        "intervention": [
            {
                "arm_group_label": "buprenorphine/naloxone", 
                "description": "MedSignals (www.medsignals.com) is a cellular communicating medication management device designed to improve adherence. It will be used to track when medication is removed from the device at dosing times and deliver audible and visual alerts at dosing times and to relay adherence data securely to patient files. Participants will use this device throughout the 5-week trial. It is a Class I device.", 
                "intervention_name": "Medsignals", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "buprenorphine/naloxone", 
                "description": "The smartphone app being evaluated in this study is designed to support effective medication management of opioid substitution patients taking buprenorphine/naloxone.", 
                "intervention_name": "smartphone app", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Buprenorphine", 
                "Analgesics, Opioid", 
                "Naloxone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "opioid dependence, buprenorphine, smartphone, suboxone", 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "email": "mbailey@medsignals.com", 
                "last_name": "Michael Bailey, PhD", 
                "phone": "866-965-9200"
            }, 
            "facility": {
                "address": {
                    "city": "Lexington", 
                    "country": "United States", 
                    "state": "Kentucky", 
                    "zip": "40507"
                }, 
                "name": "Care Team Solutions"
            }, 
            "investigator": [
                {
                    "last_name": "Vesta Brue", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Michael Bailey, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Using mHealth to Aid Opioid Medication Adherence Pilot Study", 
        "overall_contact": {
            "email": "mbailey@medsignals.com", 
            "last_name": "Michael Bailey, PhD", 
            "phone": "8669659200"
        }, 
        "overall_official": {
            "affiliation": "Care Team Solutions", 
            "last_name": "Michael Bailey, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "questionnaire assessing usability of the system.", 
            "safety_issue": "No", 
            "time_frame": "up to 5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02017041"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Care Team Solutions", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Care Team Solutions", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}